These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses. Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584 [TBL] [Abstract][Full Text] [Related]
4. PET/MRI: challenges, solutions and perspectives. Herzog H Z Med Phys; 2012 Dec; 22(4):281-98. PubMed ID: 22925652 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography. Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080 [TBL] [Abstract][Full Text] [Related]
6. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology. Schmidt GP; Kramer H; Reiser MF; Glaser C Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383 [TBL] [Abstract][Full Text] [Related]
7. An update in musculoskeletal tumors: from quantitative imaging to radiomics. Chianca V; Albano D; Messina C; Vincenzo G; Rizzo S; Del Grande F; Sconfienza LM Radiol Med; 2021 Aug; 126(8):1095-1105. PubMed ID: 34009541 [TBL] [Abstract][Full Text] [Related]
8. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. Takenaka D; Ohno Y; Matsumoto K; Aoyama N; Onishi Y; Koyama H; Nogami M; Yoshikawa T; Matsumoto S; Sugimura K J Magn Reson Imaging; 2009 Aug; 30(2):298-308. PubMed ID: 19629984 [TBL] [Abstract][Full Text] [Related]
11. Dual-time point Parghane RV; Basu S Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277 [TBL] [Abstract][Full Text] [Related]
12. Current developments and recent advances in musculoskeletal tumor imaging. Kransdorf MJ; Bridges MD Semin Musculoskelet Radiol; 2013 Apr; 17(2):145-55. PubMed ID: 23673546 [TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced Magnetic Resonance Imaging of Pelvic Bone Metastases at 3.0 T: Comparison Between 3-dimensional T1-weighted CAIPIRINHA-VIBE Sequence and 2-dimensional T1-weighted Turbo Spin-Echo Sequence. Yoon MA; Hong SJ; Lee KC; Lee CH J Comput Assist Tomogr; 2019; 43(1):46-50. PubMed ID: 29901511 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the utility of whole-body MRI with and without contrast-enhanced Quick 3D and double RF fat suppression techniques, conventional whole-body MRI, PET/CT and conventional examination for assessment of recurrence in NSCLC patients. Ohno Y; Nishio M; Koyama H; Yoshikawa T; Matsumoto S; Takenaka D; Seki S; Tsubakimoto M; Sugimura K Eur J Radiol; 2013 Nov; 82(11):2018-27. PubMed ID: 24012452 [TBL] [Abstract][Full Text] [Related]
15. Current technological advances in magnetic resonance with critical impact for clinical diagnosis and therapy. Runge VM Invest Radiol; 2013 Dec; 48(12):869-77. PubMed ID: 24126386 [TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography-CT imaging in guiding musculoskeletal biopsy. O'Sullivan PJ; Rohren EM; Madewell JE Radiol Clin North Am; 2008 May; 46(3):475-86, v. PubMed ID: 18707958 [TBL] [Abstract][Full Text] [Related]